Merck Global Health Innovation Fund announced a $5.0 million investment in Exostar to enable them to accelerate the growth and expansion of their healthcare and life science business. Exostar’s cloud-based authentication identity hub for the healthcare industry, Secure Access Manager (SAM), connects customers with other organizations securely across large communities of users. The investment, made by the Merck Global Health Innovation Fund, will help Exostar maintain its rapid growth in these markets and expand into related verticals.
The healthcare industry continues to become more reliant on secure connections, not only to ensure organizations meet all compliance issues, but to support critical digital health applications such as ePrescribing, Health Information Exchange (HIE), and clinical collaboration. Exostar leverages over a decade of experience helping companies access, utilize and share business-critical information and applications through an easy-to-use, secure Software as a Service (SaaS) model.
Originally established by some of the largest companies in the pharmaceutical and life sciences industry, the Exostar life sciences identity hub today includes more than 600 life science focused companies, government agencies and universities supporting the collaboration initiatives of thousands of individuals.
